Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson’s Disease Rat Model

Abstract EN

The aim of this study was to investigate the effect of minocycline in rats with rotenone-induced Parkinson’s disease (PD).

The open field test was performed to determine the motor ability of the rats.

Double immunofluorescence staining was used to detect the expression of tyrosine hydroxylase (TH) and Nurr1 in the substantia nigra (SN) of rats.

The relative protein levels of TH, Nurr1, and the total- and phosphorylated-cAMP-response element binding protein (CREB) were determined by western blot analysis.

The production of reactive oxygen species (ROS) and nitric oxide (NO) was detected by commercial kits.

After exposure to rotenone for 28 days, rats exhibited decreased ambulation and rearing frequency and prolonged immobility time with loss of TH positive neurons in the SN.

The phosphorylation levels of CREB and Nurr1 expression decreased significantly accompanied with the release of ROS and NO.

Minocycline alleviated the motor deficits of rats lesioned by rotenone and elevated the expression of TH, as well as suppressing the release of ROS and NO in the SN.

That was in line with the elevated phosphorylation levels of CREB and Nurr1 expression.

In conclusion, our present study showed minocycline protected against neurotoxicity in a rotenone-induced rat model of PD, which was correlated with upregulation of Nurr1.